Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992718 · ClinicalTrials.gov registry record · Early Phase 1
What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
A Early Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 49
- Enrollment target
NCT01992718: Completed Early Phase 1 study, sponsored by University of Michigan.
NCT01992718 is a Early Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 49 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992718, a Early Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
To improve the clinical care of women with pelvic pain and abnormal uterine bleeding due to benign uterine conditions including leiomyomas (uterine fibroids) and adenomyosis by evaluating the accuracy of radiology diagnostic exams (MRI(magnetic resonance imaging), ultrasound and ultrasound with elastography).
Primary Outcome
Arm 1 patients will undergo hysterectomy (per previously defined clinical decision unrelated to the study) 4-6 weeks after enrollment and imaging tests, allowing us to correlate imaging and pathologic findings
Interventions
- PROCEDURE Evaluation of MRI, US for pelvic and uterine conditions
- PROCEDURE Patient preference between MRI and Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2013-11 |
| Est. Completion | 2018-03 |
| Phase | Early Phase 1 |
What the finished NCT01992718 record still lists
NCT01992718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Evaluation of MRI, US for pelvic and uterine conditions is the first listed.
NCT01992718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01992718 about?
NCT01992718 is a clinical study titled "What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography". To improve the clinical care of women with pelvic pain and abnormal uterine bleeding due to benign uterine conditions including leiomyomas (uterine fibroids) and adenomyosis by evaluating the accuracy of radiology diagnostic exams (MRI(magnetic resonance imaging), ultrasound and ultrasound with elas...
What is the current status of trial NCT01992718?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 49 participants. The study started on 2013-11. Estimated completion is 2018-03.
What interventions are being tested in trial NCT01992718?
The interventions under investigation include: Evaluation of MRI, US for pelvic and uterine conditions (PROCEDURE), Patient preference between MRI and Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT01992718?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01992718's enrollment target sits among peer trials
49 534th of 2000 higher than 1,461 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia